Barrett Business Services, Inc.
US ˙ NasdaqGS ˙ US0684631080

Introduction

This page provides a comprehensive analysis of the known insider trading history of Mulholland Michael D.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Mulholland Michael D. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CYDY / CytoDyn Inc. Chief Financial Officer 0
US:NLS / Nautilus Inc Chief Financial Officer 0
US:BBSI / Barrett Business Services, Inc. VP Finance & Secretary 40,100
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Mulholland Michael D.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases BBSI / Barrett Business Services, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in BBSI / Barrett Business Services, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BBSI / Barrett Business Services, Inc. Insider Trades
Insider Sales BBSI / Barrett Business Services, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in BBSI / Barrett Business Services, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2005-11-23 BBSI Mulholland Michael D. 9,300 26.0194 37,200 6.5048 241,980 730 4.18 -86,484 -35.74

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BBSI / Barrett Business Services, Inc. Insider Trades
Insider Purchases CYDY / CytoDyn Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in BBSI / Barrett Business Services, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2016-10-17 CYDY Mulholland Michael D. 11,000 0.6580 11,000 0.6580 7,238 121 0.8 1,562 21.58
2014-10-15 CYDY Mulholland Michael D. 2,500 0.7900 2,500 0.7900 1,975

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CYDY / CytoDyn Inc. Insider Trades
Insider Sales CYDY / CytoDyn Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in BBSI / Barrett Business Services, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2020-12-22 CYDY Mulholland Michael D. 453,997 6.6146 453,997 6.6146 3,003,009 363 1.0000 -2,549,011 -84.88
2020-12-22 CYDY Mulholland Michael D. 12,100 7.0000 12,100 7.0000 84,700
2020-12-21 CYDY Mulholland Michael D. 585,797 5.5820 585,797 5.5820 3,269,919
2020-12-18 CYDY Mulholland Michael D. 487,002 4.9516 487,002 4.9516 2,411,439

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CYDY / CytoDyn Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Mulholland Michael D. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2020-12-28 2020-12-22 4 CYDY CytoDyn Inc.
Non-qualified Stock Option (right to buy)
M - Exercise 100,000 0 -100.00
2020-12-28 2020-12-22 4 CYDY CytoDyn Inc.
Non-qualified Stock Option (right to buy)
M - Exercise 300,000 0 -100.00
2020-12-28 2020-12-22 4 CYDY CytoDyn Inc.
Non-qualified Stock Option (right to buy)
M - Exercise 150,000 0 -100.00
2020-12-28 2020-12-22 4 CYDY CytoDyn Inc.
Non-qualified Stock Option (right to buy)
M - Exercise 161,801 0 -100.00
2020-12-28 2020-12-22 4 CYDY CytoDyn Inc.
Common Stock
S - Sale -12,100 284,081 -4.09 7.00 -84,700 1,988,567
2020-12-28 2020-12-22 4 CYDY CytoDyn Inc.
Common Stock
S - Sale -453,997 296,181 -60.52 6.61 -3,003,009 1,959,119
2020-12-28 2020-12-22 4 CYDY CytoDyn Inc.
Common Stock
S - Sale X -245,704 750,178 -24.67 5.49 -1,349,849 4,121,328
2020-12-28 2020-12-22 4 CYDY CytoDyn Inc.
Common Stock
M - Exercise 100,000 995,882 11.16 1.40 140,000 1,394,235
2020-12-28 2020-12-22 4 CYDY CytoDyn Inc.
Common Stock
M - Exercise 300,000 895,882 50.35 1.09 327,000 976,511
2020-12-28 2020-12-22 4 CYDY CytoDyn Inc.
Common Stock
M - Exercise 150,000 595,882 33.64 0.90 135,000 536,294
2020-12-28 2020-12-22 4 CYDY CytoDyn Inc.
Common Stock
M - Exercise 161,801 445,882 56.96 0.87 140,767 387,917
2020-12-21 2020-12-21 4 WAFD CytoDyn Inc.
Non-qualified Stock Option (right to buy)
M - Exercise 88,199 161,801 119.83
2020-12-21 2020-12-21 4 WAFD CytoDyn Inc.
Non-qualified Stock Option (right to buy)
M - Exercise 300,000 0 -100.00
2020-12-21 2020-12-21 4 WAFD CytoDyn Inc.
Non-qualified Stock Option (right to buy)
M - Exercise 201,598 0 -100.00
2020-12-21 2020-12-21 4 WAFD CytoDyn Inc.
Common Stock
S - Sale -589,797 284,081 -67.49 5.58 -3,292,247 1,585,740
2020-12-21 2020-12-21 4 WAFD CytoDyn Inc.
Common Stock
M - Exercise 88,199 873,878 11.23 0.87 76,733 760,274
2020-12-21 2020-12-21 4 WAFD CytoDyn Inc.
Common Stock
M - Exercise 300,000 785,679 61.77 0.80 240,000 628,543
2020-12-21 2020-12-21 4 WAFD CytoDyn Inc.
Common Stock
M - Exercise 201,598 485,679 70.96 0.57 114,911 276,837
2020-12-21 2020-12-18 4 WAFD CytoDyn Inc.
Non-qualified Stock Option (right to buy)
M - Exercise 98,402 201,598 95.35
2020-12-21 2020-12-18 4 WAFD CytoDyn Inc.
Non-qualified Stock Option (right to buy)
M - Exercise 233,100 116,900 -200.60
2020-12-21 2020-12-18 4 WAFD CytoDyn Inc.
Non-qualified Stock Option (right to buy)
M - Exercise 155,500 0 -100.00
2020-12-21 2020-12-18 4 WAFD CytoDyn Inc.
Common Stock
S - Sale -487,002 284,081 -63.16 4.95 -2,411,439 1,406,655
2020-12-21 2020-12-18 4 WAFD CytoDyn Inc.
Common Stock
M - Exercise 98,402 771,083 14.63 0.57 56,089 439,517
2020-12-21 2020-12-18 4 WAFD CytoDyn Inc.
Common Stock
M - Exercise 233,100 672,681 53.03 0.49 114,219 329,614
2020-12-21 2020-12-18 4 WAFD CytoDyn Inc.
Common Stock
M - Exercise 155,500 439,581 54.74 0.39 60,645 171,437
2020-12-21 2020-12-17 4 WAFD CytoDyn Inc.
Non-qualified Stock Option (right to buy)
M - Exercise 32,000 155,500 25.91
2020-12-21 2020-12-17 4 WAFD CytoDyn Inc.
Common Stock
S - Sale X -32,000 284,081 -10.12 4.55 -145,674 1,293,222
2020-12-21 2020-12-17 4 WAFD CytoDyn Inc.
Common Stock
M - Exercise 32,000 316,081 11.26 0.39 12,480 123,272
2020-12-21 2020-12-21 4/A CYDY CytoDyn Inc.
Common Stock
S - Sale -585,797 284,081 -67.34 5.58 -3,269,919 1,585,740
2020-12-21 2020-12-21 4/A CYDY CytoDyn Inc.
Common Stock
M - Exercise 88,199 873,878 11.23 0.87 76,733 760,274
2020-12-21 2020-12-21 4/A CYDY CytoDyn Inc.
Common Stock
M - Exercise 300,000 785,679 61.77 0.80 240,000 628,543
2020-12-21 2020-12-21 4/A CYDY CytoDyn Inc.
Common Stock
M - Exercise 201,598 485,679 70.96 0.57 114,911 276,837
2020-12-21 2020-12-18 4/A CYDY CytoDyn Inc.
Common Stock
S - Sale -487,002 284,081 -63.16 4.95 -2,411,439 1,406,655
2020-12-21 2020-12-18 4/A CYDY CytoDyn Inc.
Common Stock
M - Exercise 98,402 771,083 14.63 0.57 56,089 439,517
2020-12-21 2020-12-18 4/A CYDY CytoDyn Inc.
Common Stock
M - Exercise 233,100 672,681 53.03 0.49 114,219 329,614
2020-12-21 2020-12-18 4/A CYDY CytoDyn Inc.
Common Stock
M - Exercise 155,500 439,581 54.74 0.39 60,645 171,437
2020-12-21 2020-12-17 4/A CYDY CytoDyn Inc.
Common Stock
S - Sale X -32,000 284,081 -10.12 4.55 -145,674 1,293,222
2020-12-21 2020-12-17 4/A CYDY CytoDyn Inc.
Common Stock
M - Exercise 32,000 316,081 11.26 0.39 12,480 123,272
2020-10-02 2020-09-30 4 CYDY CytoDyn Inc.
Non-qualified Stock Option
A - Award 200,000 200,000
2020-10-02 2020-09-30 4 CYDY CytoDyn Inc.
Common Stock
A - Award 100,000 284,081 54.32
2019-12-27 2019-12-24 4 CYDY CytoDyn Inc.
Common Stock
F - Taxes -56,942 184,081 -23.63 0.64 -36,443 117,812
2019-12-27 2019-12-24 4 CYDY CytoDyn Inc.
Common Stock
A - Award 153,897 241,023 176.64
2019-12-23 2019-12-19 4 CYDY CytoDyn Inc.
Stock Option (right to buy)
A - Award 700,000 700,000
2019-10-10 2019-10-07 4/A CYDY CytoDyn Inc.
Stock Options (right to buy)
A - Award 187,500 187,500
2019-10-08 2019-10-07 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
A - Award -187,500 187,500 -50.00
2018-11-19 2018-11-16 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
A - Award 350,000 350,000
2018-11-19 2018-11-16 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
A - Award 300,000 300,000
2018-11-19 2018-11-16 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
A - Award 300,000 300,000
2018-11-19 2018-11-16 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
A - Award 300,000 300,000
2018-11-19 2018-11-16 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
A - Award 500,000 500,000
2018-11-19 2018-11-16 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
A - Award 150,000 150,000
2018-11-19 2018-11-16 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
A - Award 150,000 150,000
2018-11-19 2018-11-16 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
A - Award 100,000 100,000
2018-11-19 2018-11-16 4 CYDY CytoDyn Inc.
Common Stock
A - Award 87,126 87,126
2018-11-16 2018-11-16 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
D - Sale to Issuer -350,000 0 -100.00
2018-11-16 2018-11-16 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
D - Sale to Issuer -300,000 0 -100.00
2018-11-16 2018-11-16 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
D - Sale to Issuer -300,000 0 -100.00
2018-11-16 2018-11-16 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
D - Sale to Issuer -300,000 0 -100.00
2018-11-16 2018-11-16 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
D - Sale to Issuer -500,000 0 -100.00
2018-11-16 2018-11-16 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
D - Sale to Issuer -150,000 0 -100.00
2018-11-16 2018-11-16 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
D - Sale to Issuer -150,000 0 -100.00
2018-11-16 2018-11-16 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
D - Sale to Issuer -100,000 0 -100.00
2018-11-16 2018-11-16 4 CYDY CytoDyn Inc.
Common Stock
D - Sale to Issuer -87,126 0 -100.00
2018-06-12 2018-06-08 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
A - Award 350,000 350,000
2018-03-20 2018-03-15 4 CYDY CytoDyn Inc.
Common Stock
F - Taxes -38,733 87,126 -30.77 0.69 -26,726 60,117
2018-03-20 2018-03-15 4 CYDY CytoDyn Inc.
Common Stock
A - Award 88,816 125,859 239.76
2018-02-16 2018-02-15 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
A - Award 300,000 300,000
2018-02-16 2018-02-15 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
D - Sale to Issuer -300,000 0 -100.00
2017-06-05 2017-06-01 4 CYDY CytoDyn Inc.
Stock Options (right to buy)
A - Award 300,000 300,000
2016-10-17 2016-10-17 4 CYDY CytoDyn Inc.
Common Stock
P - Purchase 11,000 37,043 42.24 0.66 7,238 24,374
2016-06-03 2016-06-01 4 CYDY CytoDyn Inc.
Employee Stock Options (right to buy)
A - Award 300,000 300,000
2015-12-23 2015-12-21 4 CYDY CYTODYN INC
Stock Options (right to buy)
A - Award 150,000 150,000
2015-12-23 2015-12-21 4 CYDY CYTODYN INC
Stock Options (right to buy)
D - Sale to Issuer 150,000 0 -100.00
2015-12-23 2015-12-21 4 CYDY CYTODYN INC
Stock Options (right to buy)
A - Award 100,000 100,000
2015-12-23 2015-12-21 4 CYDY CYTODYN INC
Stock Options (right to buy)
D - Sale to Issuer 100,000 0 -100.00
2015-11-25 2015-11-23 4 CYDY CYTODYN INC
Employee Stock Options (right to buy)
A - Award 500,000 500,000
2015-07-01 2015-06-30 4 CYDY CYTODYN INC
Employee Stock Options (right to buy)
A - Award 150,000 150,000
2014-10-16 2014-10-15 4 CYDY CYTODYN INC
Common Stock
P - Purchase 2,500 26,043 10.62 0.79 1,975 20,574
2014-06-02 2014-05-29 4 CYDY CYTODYN INC
Employee Stock Options (right to buy)
A - Award 150,000 150,000
2013-10-16 2013-10-11 4 CYDY CYTODYN INC
Common Stock
F - Taxes -8,864 23,543 -27.35 1.35 -11,966 31,783
2013-10-16 2013-10-11 4 CYDY CYTODYN INC
Common Stock
A - Award 32,407 32,407
2013-06-03 2013-05-31 4 CYDY CYTODYN INC
Employee Stock Options (right to buy)
A - Award 300,000 300,000
2012-12-17 2012-12-13 4 CYDY CYTODYN INC
Options (right to buy)
A - Award 100,000 100,000
2011-05-09 3 NLS NAUTILUS, INC.
No securities are beneficially owned.
0
2005-11-28 2005-11-23 4 BBSI BARRETT BUSINESS SERVICES INC
Employee Stock Option (Right to Buy)
M - Exercise -9,300 40,100 -18.83
2005-11-28 2005-11-23 4 BBSI BARRETT BUSINESS SERVICES INC
Common Stock
S - Sale -9,300 500 -94.90 26.02 -241,980 13,010
2005-11-28 2005-11-23 4 BBSI BARRETT BUSINESS SERVICES INC
Common Stock
M - Exercise 9,300 9,800 1,860.00 2.00 18,600 19,600
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)